BMY — Bristol Myers Squibb

Pharmaceuticals · Health Care

S&P 500 Timeline

1957-03-04Joined S&P 500
Bristol-Myers Squibb Company engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers chemically synthesized drugs or small molecules and products produced through biological processes, called biologics.

Key Facts

StatusActive
SectorHealth Care
IndustryPharmaceuticals
Joined1957-03-04
Tenure69 yrs

Industry Peers

Sector Peers

Institutional Holdings (13F)

2,519 institutions hold BMY, totaling 2.05B shares ($118.0B) · As of 2026Q1

RankInstitutionSharesValue
1VANGUARD CAPITAL MANAGEMENT LLC264.6M$16.1B
2BlackRock, Inc.171.7M$10.4B
3STATE STREET CORP98.6M$6.0B
4JPMORGAN CHASE & CO92.5M$5.5B
5MORGAN STANLEY85.4M$4.6B
6BARCLAYS PLC81.6M$4.5B
7DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main65.8M$4.0B
8CHARLES SCHWAB INVESTMENT MANAGEMENT INC61.1M$3.7B
9GEODE CAPITAL MANAGEMENT, LLC55.3M$3.3B
10VANGUARD PORTFOLIO MANAGEMENT LLC46.2M$2.8B

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10